Hypertensive disorders of pregnancy;Hypertensions gravidiques

Revue de Medecine Interne

Volumn 23, Issue 11, 2002, Pages 927-938

  Beaufils, Michel ^a  

^a HÔPITAL TENON   (France)

Author keywords

Epidemiology; HELLP syndrome; Hypertension; Pregnancy; Therapy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE REGULATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; FETOPLACENTAL UNIT; GENETIC ANALYSIS; HELLP SYNDROME; HUMAN; INFANT WELFARE; MATERNAL HYPERTENSION; MATERNAL WELFARE; PREECLAMPSIA; PROGNOSIS; PROTEINURIA; REPRODUCTION; REVIEW; TROPHOBLAST; VASCULARIZATION;

EID: 0036855321     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00710-5     Document Type: Short Survey

References (65)

1. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy [see comments]. Am J Obstet Gynecol 1988;158:892-8.
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(S1-S22).
3. Ferguson J, Neubauer B, Shaar C. Ambulatory blood pressure monitoring during pregnancy establishment of standards of normalcy. Am J Hypertens 1994;7:838-43.
4. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
5. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing. Am J Obstet Gynecol 1990;162:311-6.
6. Hall M, Campbell D. Geographical epidemiology of preeclampsia. Proc 16th Study Group of RCOG. New York: Perinatology Press; 1987. p. 33-50.
7. Sibai BM, Taslimi MM, el Nazer A, Amon E, Mabie BC, Ryan GM. Matemal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501-9.
8. Cincotta R, Ross A. A review of eclampsia in Melbourne: 1978-1992. Aust NZ J Obstet Gynaecol 1996;36:264-7.
9. Beaufils M, Larget D, Chrétien J, Salat-Baroux J, Richet G. Hypertensions artérielles gravidiques et médecine préventive. Étude des facteurs étiologiques et du pronostic à moyen terme dans 442 cas. Bull Acad Natle Med 1983;167:413-9.
10. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: A prospective cohort study. Obstet Gynecol 1998;92:174-8.
11. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: A systematic review. Am J Obstet Gynecol 1999;181:1026-35.
12. Zhang J, Klebanoff MA, Levine RJ, Puri M, Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Obstet Gynecol 1999;181:1407-13.
13. Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994;84:626-30.
14. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
15. C.R. Brinkman, III, Assali NS. Uteroplacental hemodynamic response to antihypertensive drugs in hypertensive pregnant sheep. Perspect Nephrol Hypertens 1976;5:363-75.
16. Abitbol MM, Ober MB, Gallo GR, Driscoll SG, Pirani CL. Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone. Am J Pathol 1977;86:573-90.
17. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: Ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994;171:158-64.
18. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002;39:337-42.
19. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996;274:995-8.
20. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001;345:1400-8.
21. Le Bouteiller P. Molécules HLA, immunité et grossesse. Gynecol Obstet Fertil 2001;29:523-31.
22. Loke YW, King A. Immunological aspects of human implantation. J Reprod Fertil Suppl 2000;55:83-90.
23. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59.
24. Redman CW, Sacks GP, Sargent IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
25. Smarason A, Sargent I, Starkey P, Redman C. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993;100:943-9.
26. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222-35.
27. Delauche M, Beaufils M, Morel-Maroger L, Leroux-Robert C, Richet G. Relevance of the renal biopsy to the future course of preeclamptic women. In: Symonds E, MacGillivray L, Bonnar J, editors. Lancaster: Pregnancy Hypertension. MTP; 1980. p. 219-29.
28. Dekker G, De VJ, Doelitzsch P, Huijgens P, Von BB, Jakobs C, Jakops C, van Geijn HP. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-8.
29. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
30. Redman CW, Bodmer JG, Bodmer WF, Beilin LJ, Bonnar J. HLA antigens in severe pre-eclampsia. Lancet 1978;2:397-9.
31. Robillard P, Hulsey T, Pénanin J, Janky E, Miri E, Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994;344:973-5.
32. Smith G, Walker M, Tessier J, Millar K. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol 1997;177:455-8.
33. Dekker G. Oral tolerization to paternal antigens and preeclampsia (abstract). Amer J Obstet Gynecol 1996;174:450.
34. Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF. An epidemiologic study of contraception and preeclampsia. JAMA 1989;262:3143-7.
35. Cincotta RB, Brennecke SP. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998;60:23-7.
36. Amgrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990;97:762-9.
37. Thornton JG, Macdonald AM. Twin mothers, pregnancy hypertension and pre-eclampsia. Br J Obstet Gynaecol 1999;106:570-5.
38. Treolar S, Cooper D, Brennecke S, Grehan M, Martin N. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol 2001;184:374-81.
39. Salonen RH, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000;91:256-60.
40. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59-61.
41. Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999;180:95-102.
42. Kobashi G, Yamada H, Ohta K, Kato E, Ebina Y, Fujimoto S. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 2001;103:241-4.
43. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: Possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001;58:1943-9.
44. Arngrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, et al. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 1997;61:354-62.
45. Arngrimsson R, Sigurard S, Frigge ML, Bjarnad ttir RI, Jonsson T, Stefansson H, et al. A genome-wide scan reveals a maternal susceptibility locus for pre eclampsia on chromosome 2p13. Hum Mol Genet 1999;8:1799-805.
46. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Frigge ML, Pals G, Sigurdardottir S, et al. A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet 2001;9:758-64.
47. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of preeclampsia: Population based study. Br Med J 1998;316:1343-7.
48. Dizon-Townson D, Meline L, Nelson L, Vamer M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-5.
49. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001;357:53-6.
50. Baylis C, Beinder E, Suto T, August P. Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin Nephrol 1998;18:208-30.
51. Redman CW. Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 1991;17:149-53.
52. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: Management of hypertension in pregnancy. Br Med J 1999;318:1332-6.
53. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis. Lancet 2000;355:87-92.
54. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy (Cochrane Review). Cochrane Database Syst Rev 2000;4 CD002863.
55. Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP. Prevention of preeclampsia: A randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 1999;93:725-33.
56. Steyn D, Odendaal H. Randomised controlled trial of ketanserin and aspirin in prevention of preeclampsia. Lancet 1997;350:1267-71.
57. Sibai B. Treatment of hypertension in pregnant women. N Engl J Med 1996;336:257-65.
58. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128-35.
59. Beaufils M. Aspirine et prévention de la pré-éclampsie. Rev Med Interne 2000;21(suppl 1) 68s-74s.
60. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985;1:840-2.
61. Dekker G, Sibai B. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993;168:214-27.
62. CLASP Collaborative group. CLASP: A randomised trial of lowdose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
63. Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A meta-analysis of low-dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997;104:450-9.
64. Dumont A, Flahault A, Beaufils M, Verdy E, Uzan S. Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 1999;180:135-40.
65. Kwak JY, Gilman-Sachs A, Beaman KD, Beer AE. Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: Preconception versus postconception treatment. Am J Obstet Gynecol 1992;166:1787-95.